@article{a5b8cc946a65472eb4234ea7f14142ea,
title = "Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved",
author = "Johny Nicolas and Roxana Mehran",
note = "Funding Information: Dr Johny Nicolas has nothing to disclose. Dr Roxana Mehran reports institutional research grants from Abbott, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Boston Scientific, Bristol‐Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich, Zoll; personal fees from ACC, Boston Scientific, California Institute for Regenerative Medicine (CIRM), Cine‐Med Research, Janssen, WebMD, SCAI; consultant fees paid to the institution from Abbott Laboratories, Abiomed (spouse), Bayer (spouse), Beth Israel Deaconess, CardiaWave, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis; Equity <1% in Applied Therapeutics, Elixir Medical, STEL, CONTROLRAD (spouse); consulting (no fee) from Regeneron Pharmaceuticals; Scientific Advisory Board for AMA.",
year = "2021",
month = jun,
day = "1",
doi = "10.1002/ccd.29776",
language = "English",
volume = "97",
pages = "1470--1471",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "7",
}